2017
DOI: 10.12968/bjmh.2017.6.3.114
|View full text |Cite
|
Sign up to set email alerts
|

The use of long-acting injectable antipsychotic medication

Abstract: Evidence supports the use of long-acting injectable (LAI) antipsychotics in the treatment and prevention psychosis, but these formulations remain under-used in the UK. Overall, LAIs offer many advantages and the advent of second-generation LAIs increased interest in injectables as these newer drugs offer similar benefits to their oral equivalents. LAIs should be one of the options discussed with patients requiring long-term treatment.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 29 publications
0
1
0
Order By: Relevance
“…The clinical benefits of LAI are evident although their employment is still controversial as dosing flexibility and self-management skills might be undermined. Therefore, clinicians ought to be required to prescribe LAI treatments on a case by case basis by evaluating patient's risks and benefits (Mutsatsa 2017).…”
Section: Technological and Regulatory Barriersmentioning
confidence: 99%
“…The clinical benefits of LAI are evident although their employment is still controversial as dosing flexibility and self-management skills might be undermined. Therefore, clinicians ought to be required to prescribe LAI treatments on a case by case basis by evaluating patient's risks and benefits (Mutsatsa 2017).…”
Section: Technological and Regulatory Barriersmentioning
confidence: 99%